ArticleHormones (Athens, Greece)2025
Causal associations between thyroid function and sarcopenia-related traits: a Mendelian randomization study.
Article in Hormones (Athens, Greece), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Novel Sarcopenia Screening Score Based on Thyroid Function Parameters in Euthyroid Middle-Aged and Elderly Chinese Adults.International journal of endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
BACKGROUND AND
objectiveAs the global population ages, the incidence of sarcopenia increases, resulting in increasing numbers of patients with impairments in physical function. Thyroid function disorders may contribute to the pathogenesis of sarcopenia. This study aimed to establish a causal relationship between thyroid hormones (TH) and sarcopenia using a two-sample Mendelian randomization (MR) analysis method. STUDY
designA two-sample MR study was conducted using summary-level data from genome-wide association studies (GWAS) which included publicly available pooled statistics for thyroid-stimulating hormone (TSH), free thyroxine (FT4), free triiodothyronine (FT3), and the FT3 to FT4 ratio from the Thyroidomics Consortium, as well as summary statistics for sarcopenia-related traits, such as appendicular lean mass (ALM), whole-body lean mass (WBLM), grip strength (left and right), and walking pace from the UK Biobank. The MR analysis used genetic exposure tools for assessment of thyroid function (TSH, FT4, FT3, and the FT3 to FT4 ratio) and outcome measures for sarcopenia (ALM, WBLM, grip strength, and walking pace). The inverse variance weighted method was employed to estimate the genetic predictions of the causal effect of thyroid function on sarcopenia risk. Sensitivity analyses were also conducted to validate the reliability of the MR results.
resultsCorrelations were observed between ALM and several indicators, as follows: TSH (OR: 1.03; 95% CI: 1.01-1.04), FT4 (OR: 0.95; 95% CI: 0.93-0.98), FT3 (OR: 1.09; 95% CI: 1.03-1.15), and the FT3 to FT4 ratio (OR: 1.25; 95% CI: 1.11-1.42). Furthermore, causal relationships were identified between WBLM and TSH (OR: 1.02; 95% CI: 1.01-1.03), as well as low TSH (OR: 0.99; 95% CI: 0.99-1.00) and high TSH (OR: 0.97; 95% CI: 0.96-1.00). Walking pace was associated with low TSH (OR: 0.99; 95% CI: 0.99-1.00), whereas grip strength was related to TSH (OR: 1.01; 95% CI: 1.00-1.02) and low TSH (OR: 0.99; 95% CI: 0.99-1.00). High TSH (OR: 1.04; 95% CI: 1.01-1.08) and FT3 (OR: 0.96; 95% CI: 0.92-1.00) levels were associated with right grip strength.
conclusionThese results indicate a causal relationship between thyroid function and sarcopenia, highlighting FT3 and the FT3 to FT4 ratio as key indicators. However, total triiodothyronine (TT3) emerges as a potential indicator that requires further investigation in future studies.
Indexed as
Identifiers
40278995What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.